CSIMarket



Allovir Inc.  (ALVR)
Other Ticker:  
 
 

ALVR's Operating Income Growth by Quarter and Year

Allovir's Operating Income results by quarter and year




ALVR Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -55.80 36.05 0.00
III Quarter September - -45.50 -23.90 0.00
II Quarter June -44.62 -37.66 -12.15 0.00
I Quarter March -43.19 -30.86 0.00 0.00
FY   -87.81 -169.82 -0.00 -



ALVR Operating Income second quarter 2022 Y/Y Growth Comment
Allovir Inc. in the second quarter 2022 recorded Operating Loss of $ -44.62 millions.

According to the results reported in the second quarter 2022, Allovir Inc. achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Allovir Inc.' s Operating Income no change of % ranks overall at the positon no. in the second quarter 2022.

Explain Operating Income growth


ALVR Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Allovir's second quarter 2022 Operating Income $ -44.62 millions ALVR's Income Statement
Allovir's second quarter 2021 Operating Income $ -37.66 millions Quarterly ALVR's Income Statement
New: More ALVR's historic Operating Income Growth >>


ALVR Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Allovir's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALVR's II. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -44.62 millions by Allovir Inc. look even worse compare to the Operating Loss -43.19 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Allovir Inc. achieved highest sequential Operating Income growth. While Allovir's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALVR's II. Quarter Q/Q Operating Income Comment
II. Quarter 2022 accomplishment of -44.62 millions by Allovir Inc. appear even more unfavourable if you take a look at -43.19 millions Operating Loss in the first quarter.

Within Biotechnology & Pharmaceuticals industry Allovir Inc. achieved highest sequential Operating Income growth. While Allovir's Operating Income growth quarter on quarter, overall rank is .


Allovir's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Operating Income 12 Months Ending $ -189.12 $ -182.15 $ -169.82 $ -77.97 $ -56.37
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Allovir Inc.' has realized cumulative trailing twelve months Operating Loss of $ -189 millions in the Jun 30 2022 period.
The business is worsening as the cumulative Operating Loss is inflating from $ -182.15 millions in TTM ending quarter Mar 31 2022 and $ -43.19 millions for the twelve months ending in the quarter Jun 30 2021.

Allovir Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Allovir Inc.' has realized cumulative trailing twelve months Operating Loss of $ -189 millions in the Jun 30 2022 period.
The business is detiriorating as the cumulative Operating Loss is becoming larger from $ -182.15 millions in TTM ending quarter Mar 31 2022 and $ -43.19 millions for the twelve months ending in the quarter a year ago.

Allovir Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ALVR's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ALVR's Competitors
Operating Income Growth for Allovir's Suppliers
Operating Income Growth for ALVR's Customers

You may also want to know
ALVR's Annual Growth Rates ALVR's Profitability Ratios ALVR's Asset Turnover Ratio ALVR's Dividend Growth
ALVR's Roe ALVR's Valuation Ratios ALVR's Financial Strength Ratios ALVR's Dividend Payout Ratio
ALVR's Roa ALVR's Inventory Turnover Ratio ALVR's Growth Rates ALVR's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2022
Pacific Health Care Organization Inc.31.48%$ 31.477 millions
Repligen Corp30.95%$ 30.945 millions
Surgery Partners Inc.28.57%$ 28.571 millions
Chemed Corporation28.23%$ 28.228 millions
Zimmer Biomet Holdings Inc.27.39%$ 27.392 millions
Option Care Health Inc.22.84%$ 22.840 millions
Ensign Group Inc20.63%$ 20.628 millions
Phibro Animal Health Corporation19.46%$ 19.459 millions
Bio techne Corp17.48%$ 17.482 millions
Maravai Lifesciences Holdings Inc.17.15%$ 17.152 millions
Avantor Inc.16.06%$ 16.058 millions
Integra Lifesciences Holdings Corp15.45%$ 15.453 millions
Sonida Senior Living Inc.15.35%$ 15.346 millions
Zynex inc.14.39%$ 14.391 millions
Atrion Corporation12.60%$ 12.598 millions
Diffusion Pharmaceuticals Inc.10.77%$ 10.766 millions
Mettler Toledo International Inc10.39%$ 10.390 millions
Protokinetix Incorporated9.52%$ 9.516 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SIDU's Profile

Stock Price

SIDU's Financials

Business Description

Fundamentals

Charts & Quotes

SIDU's News

Suppliers

SIDU's Competitors

Customers & Markets

Economic Indicators

SIDU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071